1. Home
  2. GCO vs TBPH Comparison

GCO vs TBPH Comparison

Compare GCO & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCO
  • TBPH
  • Stock Information
  • Founded
  • GCO 1924
  • TBPH 2013
  • Country
  • GCO United States
  • TBPH United States
  • Employees
  • GCO N/A
  • TBPH N/A
  • Industry
  • GCO Clothing/Shoe/Accessory Stores
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • GCO Consumer Discretionary
  • TBPH Health Care
  • Exchange
  • GCO Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • GCO 472.3M
  • TBPH 485.8M
  • IPO Year
  • GCO N/A
  • TBPH N/A
  • Fundamental
  • Price
  • GCO $40.28
  • TBPH $8.58
  • Analyst Decision
  • GCO Hold
  • TBPH Buy
  • Analyst Count
  • GCO 1
  • TBPH 4
  • Target Price
  • GCO $31.00
  • TBPH $13.75
  • AVG Volume (30 Days)
  • GCO 207.3K
  • TBPH 166.7K
  • Earning Date
  • GCO 03-07-2025
  • TBPH 02-24-2025
  • Dividend Yield
  • GCO N/A
  • TBPH N/A
  • EPS Growth
  • GCO N/A
  • TBPH N/A
  • EPS
  • GCO N/A
  • TBPH N/A
  • Revenue
  • GCO $2,318,063,000.00
  • TBPH $63,192,000.00
  • Revenue This Year
  • GCO $0.58
  • TBPH $11.41
  • Revenue Next Year
  • GCO $1.75
  • TBPH $37.36
  • P/E Ratio
  • GCO N/A
  • TBPH N/A
  • Revenue Growth
  • GCO 0.32
  • TBPH 15.93
  • 52 Week Low
  • GCO $23.21
  • TBPH $7.44
  • 52 Week High
  • GCO $44.80
  • TBPH $10.44
  • Technical
  • Relative Strength Index (RSI)
  • GCO 49.31
  • TBPH 33.59
  • Support Level
  • GCO $38.99
  • TBPH $8.35
  • Resistance Level
  • GCO $43.00
  • TBPH $8.86
  • Average True Range (ATR)
  • GCO 1.96
  • TBPH 0.28
  • MACD
  • GCO -0.54
  • TBPH -0.11
  • Stochastic Oscillator
  • GCO 26.87
  • TBPH 14.74

About GCO Genesco Inc.

Genesco Inc sells footwear, headwear, sports apparel, and accessories. The company has four reportable segments namely Journeys Group, derives maximum revenue which comprised of Journeys, Journeys Kidz, and Little Burgundy retail footwear chains, e-commerce operations, and catalog. Its Schuh Group is comprised of the Schuh retail footwear chain and e-commerce operations. The Johnston & Murphy Group is comprised of Johnston & Murphy retail operations, e-commerce operations, and catalog and wholesale distribution of products under the Johnston & Murphy and Genesco Brands Group. Licensed Brands, comprised of Dockers Footwear, under a license from Levi Strauss & Company.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: